Discovery of a Novel Mode of Protein Kinase Inhibition Characterized by the Mechanism of Inhibition of Human Mesenchymal-epithelial Transition Factor (c-Met) Protein Autophosphorylation by ARQ 197

This publication has 41 references indexed in Scilit:

• Developing c-MET pathway inhibitors for cancer therapy: progress and challenges
  Trends in Molecular Medicine, 2010
• Analysis of c‐Met Kinase Domain Complexes: A New Specific Catalytic Site Receptor Model for Defining Binding Modes of ATP‐Competitive Ligands
  Chemical Biology & Drug Design, 2009
• Type-II Kinase Inhibitor Docking, Screening, and Profiling Using Modified Structures of Active Kinase States
  Journal of Medicinal Chemistry, 2008
• Automated macromolecular model building for X-ray crystallography using ARP/wARP version 7
  Nature Protocols, 2008
• Biochemical Basis for the Functional Switch That Regulates Hepatocyte Growth Factor Receptor Tyrosine Kinase Activation
  Biochemistry, 2008
• MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling
  Science, 2007
• The 2.7 Å Crystal Structure of the Autoinhibited Human c-Fms Kinase Domain
  Journal of Molecular Biology, 2007
• Surface comparison of active and inactive protein kinases identifies a conserved activation mechanism
  Proceedings of the National Academy of Sciences, 2006
• The Structural Basis for Autoinhibition of FLT3 by the Juxtamembrane Domain
  Molecular Cell, 2004
• The CCP4 suite: programs for protein crystallography
  Acta Crystallographica Section D Structural Biology, 1994